Drug intelligence / Profile preview

oyster mushroom

Development stage: Preclinical
Modality: Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Oyster mushroom (Pleurotus ostreatus) is an edible fungus with medicinal properties. It contains beta-glucans and other bioactive compounds that provide various health benefits. It's rich in nutrients including B vitamins, minerals, and the antioxidant amino acid ergothioneine. Research suggests it may support immune function, help regulate cholesterol and blood sugar levels, reduce inflammation, and potentially have anti-tumor properties.

Other names: Pleurotus ostreatusBrown oyster mushroomHao gu

Targets

HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)

Beyond the preview

Go deeper on oyster mushroom.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on oyster mushroom.

Explore the full profile